Very late stent thrombosis of a paclitaxel-eluting stent after left main coronary artery stenting
. Because the result was satisfactory ( fig. 1-III) , no further intervention was performed (dilatation of the circumflex ostium or final kissing balloon). The recovery was uneventful and the patient was discharged after 3 days. Aspirin ® was prescribed for the remainder of his life and clopidogrel was prescribed for 12 months.
Seven-hundred thirty days after stent implantation, the patient complained of acute chest pain. During his transport to the cathlab, the patient presented pulseless electrical activity (PEA) requiring chest compressions, endotracheal intubation and administration of pressors. The coronary angiography ( fig. 2 ) was repeated and revealed a total occlusion of the distal left main coronary artery due to stent thrombosis ( fig. 2-I , the arrow shows a large thrombus). The patient underwent percutaneous coronary intervention under chest compressions, which allowed a TIMI-2 flow in the LAD to be restored ( fig. 2-II, arrow) . A resting high-grade stenosis of ostium of RCX ( fig.  2 -II, light arrow) was finally treated with implantation of a 3.5/10 mm titanox-eluting stent (Titan-2 ® , Hexacath). Although the result was satisfactory with restoration of efficient blood flow in the left coronary tree, the left ventricular ejection fraction remained severely depressed and the patient died in cardiogenic shock. The family refused autopsy.
Discussion
Drug-eluting stents have been shown to effectively reduce neointimal hyperplasia, which make them a competitive alternative to coronary artery bypass surgery for patients suffering from left main coronary artery disease.
There is, however, a growing body of concerns about late-occurring stent thrombosis in the current drug-eluting stent era [1] . When very late stent thrombosis (ST >1 year after implantation) remains the exception with bare-metal stent (2% of all stent thrombosis) [2] , about one third of drug-eluting stent -ST appear very late [1] . Very late ST is most likely a multifactorial process related to disturbed vasomotion, incomplete reendothelialisation,chronic inflammation with positive vessel remodeling, incomplete stent apposition and / or insufficient inhibition of platelet aggregation. Accordingly, recent investigations have reported variables consistently associated with ST following drug-eluting stent implantation, such as discontinuation of antiplatelet therapy, brachytherapy, bifurcation stenting, acute coronary syndromes, renal insufficiency, current smoking, left main coronary PCI and diabetes [3, 4] . Furthermore, incomplete stent apposition and stent underexpansion have been identified in IVUS studies [5, 6] , and hypersensitivity reactions and localised inflammation have been recognised in autopsy proven ST cases [7, 8] .
Whereas the exact causes leading to stent thrombosis in this particular case will stay unanswered (lack of final kissing balloon, stent underexpansion or malapposition, hypersensitivity, aspirin ® resistance?), this current example highlights however that late stent thrombosis may occur with drug-eluting stents, which requires careful clinical follow-up and particularly so with stents implanted into the left main coronary artery.
